tipifarnib has been researched along with Carcinoma, Epidermoid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adkins, DR; Bruce, JY; Burrows, F; Chan, S; Dale, S; Dayoub, A; Gascó Hernández, A; Gutkind, JS; Hanna, GJ; Ho, AL; Kessler, L; Koshizuka, K; Malik, S; McCloskey, A; Patel, HV; Perez, CA; Reilly, Q; Saunders, A; Smith, AE; Soifer, HS; Villaflor, V; Wang, JZ; Wang, Z | 1 |
| Grandis, JR; Johnson, DE; Lee, RH | 1 |
| Fernandez-Juarez, G; Gimenez-Moyano, S; Guerrero-Marquez, C; Martinez de la Cruz, P; Mielgo-Rubio, X; Shabaka, A | 1 |
| Cohen, PR; Diwan, AH; Evans, HL; Hong, DS; Kurzrock, R; Prieto, VG; Reddy, SB; Tannir, NM; Wright, JJ | 1 |
| Abbruzzese, A; Caraglia, M; Giordano, A; Giuberti, G; Grimaldi, A; Lombardi, A; Misso, G; Ricciardiello, F; Tagliaferri, P | 1 |
1 review(s) available for tipifarnib and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Concomitant Acute Tubular Necrosis and Acute Interstitial Nephritis Induced by Tipifarnib in a Patient with Squamous Cell Carcinoma of the Lung.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Kidney Cortex Necrosis; Lung Neoplasms; Male; Nephritis, Interstitial; Quinolones | 2021 |
4 other study(ies) available for tipifarnib and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Tipifarnib Potentiates the Antitumor Effects of PI3Kα Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity.
Topics: Biomarkers; Carcinoma, Squamous Cell; Class I Phosphatidylinositol 3-Kinases; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Proto-Oncogene Proteins p21(ras); Squamous Cell Carcinoma of Head and Neck; TOR Serine-Threonine Kinases | 2023 |
To Tip or Not to Tip: A New Combination for Precision Medicine in Head and Neck Cancer.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Head and Neck Neoplasms; Humans; Precision Medicine; Proto-Oncogene Proteins p21(ras); Squamous Cell Carcinoma of Head and Neck; TOR Serine-Threonine Kinases | 2023 |
Multiple squamous cell carcinomas of the skin after therapy with sorafenib combined with tipifarnib.
Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Biopsy; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Niacinamide; Phenylurea Compounds; Pyridines; Quinolones; Receptors, Vascular Endothelial Growth Factor; Skin Neoplasms; Sorafenib | 2008 |
Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC.
Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Synergism; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Quinolones; ras Proteins; Signal Transduction; Taxoids | 2013 |